- About this Journal ·
- Abstracting and Indexing ·
- Aims and Scope ·
- Annual Issues ·
- Article Processing Charges ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Recently Accepted Articles ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
BioMed Research International
Volume 2013 (2013), Article ID 760236, 9 pages
Heparanase Localization during Palatogenesis in Mice
1Department of Anatomy and Cell Biology, Faculty of Medicine, Osaka Medical College, Takatsuki 569-8686, Japan
2Laboratory of Veterinary Physiology, Nippon Veterinary and Life Science University, Musashino 180-8602, Japan
3Graduate School of Environmental and Life Science, Okayama University, Okayama 700-8530, Japan
4Division of Research and Treatment for Oral and Maxillofacial Congenital Anomalies, School of Dentistry, Aichi Gakuin University, Nagoya 464-0821, Japan
5Departments of Material and Life Science, Graduate School of Engineering, Osaka University, Suita 565-0871, Japan
6Laboratory of Biological Chemistry, Department of Biomolecular Chemistry, Kyoto Prefectural University, Kyoto 606-8522, Japan
7Department of Oral Histology, Matsumoto Dental University, Shiojiri 399-0781, Japan
Received 14 November 2012; Accepted 1 January 2013
Academic Editor: Erica L. Scheller
Copyright © 2013 Azumi Hirata et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- M. W. Ferguson, “Palate development,” Development, vol. 103, supplement, pp. 41S–60S, 1988.
- L. Meng, Z. Bian, R. Torensma, and J. W. Von Den Hoff, “Biological mechanisms in palatogenesis and cleft palate,” Journal of Dental Research, vol. 88, no. 1, pp. 22–33, 2009.
- J. Morris-Wiman and L. Brinkley, “Rapid changes in the extracellular matrix accompany in vitro palatal shelf remodelling,” Anatomy and Embryology, vol. 188, no. 1, pp. 75–85, 1993.
- J. Morris-Wiman and L. Brinkley, “An extracellular matrix infrastructure provides support for murine secondary palatal shelf remodelling,” Anatomical Record, vol. 234, no. 4, pp. 575–586, 1992.
- A. Iamaroon and V. M. Diewert, “Distribution of basement membrane components in the mouse primary palate,” Journal of Craniofacial Genetics and Developmental Biology, vol. 16, no. 1, pp. 48–51, 1996.
- M. Dudas, W. Y. Li, J. Kim, A. Yang, and V. Kaartinen, “Palatal fusion—where do the midline cells go?. A review on cleft palate, a major human birth defect,” Acta Histochemica, vol. 109, no. 1, pp. 1–14, 2007.
- L. Blavier, A. Lazaryev, J. Groffen, N. Heisterkamp, Y. A. DeClerck, and V. Kaartinen, “TGF-β3-induced palatogenesis requires matrix metalloproteinases,” Molecular Biology of the Cell, vol. 12, no. 5, pp. 1457–1466, 2001.
- N. L. Brown, S. J. Yarram, J. P. Mansell, and J. R. Sandy, “Matrix metalloproteinases have a role in palatogenesis,” Journal of Dental Research, vol. 81, no. 12, pp. 826–830, 2002.
- M. D. Hulett, C. Freeman, B. J. Hamdorf, R. T. Baker, M. J. Harris, and C. R. Parish, “Cloning of mammalian heparanase, an important enzyme in tumor invasion and metastasis,” Nature Medicine, vol. 5, no. 7, pp. 803–809, 1999.
- M. Toyoshima and M. Nakajima, “Human heparanase. Purification, characterization, cloning, and expression,” The Journal of Biological Chemistry, vol. 274, no. 34, pp. 24153–24160, 1999.
- I. Vlodavsky, Y. Friedmann, M. Elkin et al., “Mammalian heparanase: gene cloning, expression and function in tumor progression and metastasis,” Nature Medicine, vol. 5, no. 7, pp. 793–802, 1999.
- J. Kruegel and N. Miosge, “Basement membrane components are key players in specialized extracellular matrices,” Cellular and Molecular Life Sciences, vol. 67, no. 17, pp. 2879–2895, 2010.
- E. McKenzie, K. Tyson, A. Stamps et al., “Cloning and expression profiling of Hpa2, a novel mammalian heparanase family member,” Biochemical and Biophysical Research Communications, vol. 276, no. 3, pp. 1170–1177, 2000.
- F. Levy-Adam, S. Feld, V. Cohen-Kaplan et al., “Heparanase 2 interacts with heparan sulfate with high affinity and inhibits heparanase activity,” The Journal of Biological Chemistry, vol. 285, no. 36, pp. 28010–28019, 2010.
- A. Hirata and H. Nakamura, “Localization of perlecan and heparanase in Hertwig's epithelial root sheath during root formation in mouse molars,” Journal of Histochemistry and Cytochemistry, vol. 54, no. 10, pp. 1105–1113, 2006.
- H. Q. Miao, E. Navarro, S. Patel et al., “Cloning, expression, and purification of mouse heparanase,” Protein Expression and Purification, vol. 26, no. 3, pp. 425–431, 2002.
- H. Nakamura and H. Ozawa, “Immunohistochemical localization of heparan sulfate proteoglycan in rat tibiae,” Journal of Bone and Mineral Research, vol. 9, no. 8, pp. 1289–1299, 1994.
- W. J. Grzesik, C. R. Frazier, J. R. Shapiro, P. D. Sponseller, P. Gehron Robey, and N. S. Fedarko, “Age-related changes in human bone proteoglycan structure: impact of osteogenesis imperfecta,” The Journal of Biological Chemistry, vol. 277, no. 46, pp. 43638–43647, 2002.
- P. Newman, F. Bonello, A. S. Wierzbicki, P. Lumb, G. F. Savidge, and M. J. Shearer, “The uptake of lipoprotein-borne phylloquinone (vitamin K1) by osteoblasts and osteoblast-like cells: role of heparan sulfate proteoglycans and apolipoprotein E,” Journal of Bone and Mineral Research, vol. 17, no. 3, pp. 426–433, 2002.
- S. M. Cool and V. Nurcombe, “The osteoblast-heparan sulfate axis: control of the bone cell lineage,” International Journal of Biochemistry and Cell Biology, vol. 37, no. 9, pp. 1739–1745, 2005.
- S. A. Khan, M. S. Nelson, C. Pan, P. M. Gaffney, and P. Gupta, “Endogenous heparan sulfate and heparin modulate bone morphogenetic protein-4 signaling and activity,” American Journal of Physiology, vol. 294, no. 6, pp. C1387–C1397, 2008.
- M. Saijo, R. Kitazawa, M. Nakajima, M. Kurosaka, S. Maeda, and S. Kitazawa, “Heparanase mRNA expression during fracture repair in mice,” Histochemistry and Cell Biology, vol. 120, no. 6, pp. 493–503, 2003.
- V. Kram, E. Zcharia, O. Yacoby-Zeevi et al., “Heparanase is expressed in osteoblastic cells and stimulates bone formation and bone mass,” Journal of Cellular Physiology, vol. 207, no. 3, pp. 784–792, 2006.
- P. N. Smith, C. Freeman, D. Yu et al., “Heparanase in primary human osteoblasts,” Journal of Orthopaedic Research, vol. 28, no. 10, pp. 1315–1322, 2010.
- W. R. Thompson, S. Modla, B. J. Grindel et al., “Perlecan/Hspg2 deficiency alters the pericellular space of the lacunocanalicular system surrounding osteocytic processes in cortical bone,” Journal of Bone and Mineral Research, vol. 26, no. 3, pp. 618–629, 2011.
- E. Zcharia, D. Philp, E. Edovitsky et al., “Heparanase regulates murine hair growth,” American Journal of Pathology, vol. 166, no. 4, pp. 999–1008, 2005.
- S. Malgouries, M. Donovan, S. Thibaut, and B. A. Bernard, “Heparanase 1: a key participant of inner root sheath differentiation program and hair follicle homeostasis,” Experimental Dermatology, vol. 17, no. 12, pp. 1017–1023, 2008.
- D. Bernard, B. Méhul, C. Delattre, L. Simonetti, A. Thomas-Collignon, and R. Schmidt, “Purification and characterization of the endoglycosidase heparanase 1 from human plantar stratum corneum: a key enzyme in epidermal physiology?” Journal of Investigative Dermatology, vol. 117, no. 5, pp. 1266–1273, 2001.
- O. Goldshmidt, L. Nadav, H. Aingorn et al., “Human heparanase is localized within lysosomes in a stable form,” Experimental Cell Research, vol. 281, no. 1, pp. 50–62, 2002.
- A. Zetser, F. Levy-Adam, V. Kaplan et al., “Processing and activation of latent heparanase occurs in lysosomes,” Journal of Cell Science, vol. 117, no. 11, pp. 2249–2258, 2004.
- N. J. Nasser, “Heparanase involvement in physiology and disease,” Cellular and Molecular Life Sciences, vol. 65, no. 11, pp. 1706–1715, 2008.
- C. R. Parish, “The role of heparan sulphate in inflammation,” Nature Reviews Immunology, vol. 6, no. 9, pp. 633–643, 2006.
- C. Kirn-Safran, M. C. Farach-Carson, and D. D. Carson, “Multifunctionality of extracellular and cell surface heparan sulfate proteoglycans,” Cellular and Molecular Life Sciences, vol. 66, no. 21, pp. 3421–3434, 2009.
- A. D. Theocharis, S. S. Skandalis, G. N. Tzanakakis, and N. K. Karamanos, “Proteoglycans in health and disease: novel roles for proteoglycans in malignancy and their pharmacological targeting,” The FEBS Journal, vol. 277, no. 19, pp. 3904–3923, 2010.
- S. H. Kim, J. Turnbull, and S. Guimond, “Extracellular matrix and cell signalling: the dynamic cooperation of integrin, proteoglycan and growth factor receptor,” Journal of Endocrinology, vol. 209, no. 2, pp. 139–151, 2011.
- H. J. Ra and W. C. Parks, “Control of matrix metalloproteinase catalytic activity,” Matrix Biology, vol. 26, no. 8, pp. 587–596, 2007.
- E. Zcharia, J. Jia, X. Zhang et al., “Newly generated heparanase knock-out mice unravel co-regulation of heparanase and matrix metalloproteinases,” PLoS ONE, vol. 4, no. 4, Article ID e5181, 2009.
- C. Martínez-Álvarez, C. Tudela, J. Pérez-Miguelsanz, S. O'Kane, J. Puerta, and M. W. J. Ferguson, “Medial edge epithelial cell fate during palatal fusion,” Developmental Biology, vol. 220, no. 2, pp. 343–357, 2000.
- R. Cuervo and L. Covarrubias, “Death is the major fate of medial edge epithelial cells and the cause of basal lamina degradation during palatogenesis,” Development, vol. 131, no. 1, pp. 15–24, 2004.
- J. Z. Jin and J. Ding, “Analysis of cell migration, transdifferentiation and apoptosis during mouse secondary palate fusion,” Development, vol. 133, no. 17, pp. 3341–3347, 2006.
- F. V. Sani, K. Hallberg, B. D. Harfe, A. P. McMahon, A. Linde, and A. Gritli-Linde, “Fate-mapping of the epithelial seam during palatal fusion rules out epithelial-mesenchymal transformation,” Developmental Biology, vol. 285, no. 2, pp. 490–495, 2005.
- A. Lochter, S. Galosy, J. Muschler, N. Freedman, Z. Werb, and M. J. Bissell, “Matrix metalloproteinase stromelysin-1 triggers a cascade of molecular alterations that leads to stable epithelial-to-mesenchymal conversion and a premalignant phenotype in mammary epithelial cells,” Journal of Cell Biology, vol. 139, no. 7, pp. 1861–1872, 1997.